HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuri V Sergeev Selected Research

Oculocutaneous albinism type 1

7/2021Characterization of Temperature-Dependent Kinetics of Oculocutaneous Albinism-Causing Mutants of Tyrosinase.
1/2018Dynamic analysis of human tyrosinase intra-melanosomal domain and mutant variants to further understand oculocutaneous albinism type 1.
12/2017The consequences of deglycosylation of recombinant intra-melanosomal domain of human tyrosinase.
1/2017Purification of Recombinant Human Tyrosinase from Insect Larvae Infected with the Baculovirus Vector.
1/2017Oculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity.
10/2011Nitisinone improves eye and skin pigmentation defects in a mouse model of oculocutaneous albinism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuri V Sergeev Research Topics

Disease

7Oculocutaneous Albinism (Albinism, Yellow Mutant)
01/2022 - 10/2011
6Oculocutaneous albinism type 1
07/2021 - 10/2011
4Eye Diseases (Eye Disease)
01/2021 - 12/2016
4Cataract (Cataracts)
12/2016 - 09/2005
3Inborn Genetic Diseases (Disease, Hereditary)
01/2021 - 12/2016
3Blindness (Hysterical Blindness)
12/2016 - 01/2014
3Macular Degeneration (Age-Related Maculopathy)
12/2016 - 11/2013
2Albinism
01/2017 - 01/2014
2Leber Congenital Amaurosis
01/2016 - 06/2010
2Autoimmune Diseases (Autoimmune Disease)
06/2014 - 10/2005
2Uveitis
06/2014 - 10/2005
1type 1B Usher syndrome
01/2021
1Coloboma (Colobomas)
01/2020
1Glaucoma
12/2016
1Microphthalmos
12/2016
1Retinitis Pigmentosa (Pigmentary Retinopathy)
12/2016
1Ciliopathies
07/2015
1Rare Diseases (Rare Disease)
11/2014
1Infections
06/2014
1Neoplasm Metastasis (Metastasis)
06/2014
1Neoplasms (Cancer)
06/2014
1Retinal Degeneration
12/2013
1Retinoschisis (Retinoschisis, Juvenile)
12/2013
1Choroideremia
12/2009
1B-Cell Lymphoma (Lymphoma, B Cell)
10/2005

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
01/2021 - 12/2009
8Monophenol Monooxygenase (Tyrosinase)IBA
07/2021 - 10/2011
6Melanins (Melanin)IBA
07/2021 - 10/2011
2Crystallins (Crystallin)IBA
08/2009 - 06/2008
1Cysteine (L-Cysteine)FDA Link
01/2022
1dopachromeIBA
01/2021
1Myosin VIIaIBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1retinoic acid receptor betaIBA
01/2020
1AsparagineIBA
12/2017
1MyoglobinIBA
01/2017
1Microphthalmia-Associated Transcription FactorIBA
12/2016
1Retinaldehyde (Retinal)IBA
01/2016
1Glycoproteins (Glycoprotein)IBA
11/2014
1Fibrillin-2IBA
11/2014
1ElastinIBA
11/2014
1Interleukin-10 (Interleukin 10)IBA
06/2014
1Complement C3 (C3 Complement)IBA
11/2013
1nitisinone (Orfadin)FDA Link
10/2011
1Mutant Proteins (Protein, Mutant)IBA
06/2010
1Membrane Proteins (Integral Membrane Proteins)IBA
06/2008
1Transcription Factors (Transcription Factor)IBA
06/2008
1Intermediate Filament ProteinsIBA
06/2008
1ConnexinsIBA
06/2008
1interstitial retinol-binding proteinIBA
10/2005
1Immunodominant EpitopesIBA
10/2005
1ElementsIBA
10/2005
1beta-CrystallinsIBA
09/2005

Therapy/Procedure

1Aftercare (After-Treatment)
06/2014